CHU - Hôpital Saint Louis - Centre D'Investigations Cliniq
Paris 75010
0 studies enrolling now · 1 studies all time
What they study most
Myelofibrosis
Studies at this site
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
— Running, not enrolling